Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
McKesson
AstraZeneca
McKinsey
Baxter
Merck

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-12-11
Court District Court, D. Delaware Date Terminated 2019-08-29
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Plaintiff Referred To
Parties ACTAVIS LABORATORIES UT INC.; GALDERMA LABORATORIES L.P.; GALDERMA SA; NESTLE SKIN HEALTH S.A.; TEVA PHARMACEUTICAL INDUSTRIES LTD; TEVA PHARMACEUTICALS U.S.A., INC.
Patents 5,952,372; 6,133,310; 7,550,440; 8,080,530; 8,093,219; 8,415,311; 8,470,788; 8,815,816; 9,089,587; 9,233,117; 9,233,118; 9,782,425
Attorneys Ashley Ross; Chad J. Ray; Christopher T. Jagoe; Jack B. Blumenfeld; Jamil N. Alibhai; Jeremy A. Tigan; Jordan C. Strauss; Justin Bova; Karen Elizabeth Keller; Kelly P. Chen; Kristen P.L. Reichenbach; Leora Ben-Ami; Michael C. Wilson; Nathan Roger Hoeschen; Thomas F. Fleming
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Cover Sheet US Patent No. 8,362,069, # 2 Exhibit(s) B - US Patent No. 8,815,816, # 3 Exhibit(s) C - US Patent No.…9,089,587, # 4 Exhibit(s) D - US Patent No. 9,233,117, # 5 Exhibit(s) E - US Patent No. 9,233,118, # 6 Cover …2017 29 August 2019 1:17-cv-01783 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 124 argues for a construction drawn from U.S . Patent No . 6,133,310 ("Parks"), which is incorporated… six patents from three patent families against Defendant. (D.I. 110 at 1). The ' 587 Patent, the…the ' 117 Patent, the ' 118 Patent, and the '425 Patent are members of the Jacovella … history of the '249 Patent, a patent extrinsic to the ' 069 Patent, provides at least some support…of multiple terms in U.S. Patent Nos. 8,815,816 (the "' 816 Patent"), 8,362,069 (the " External link to document
0000-00-00 128 of U.S. Patent No. 8,815,816 (the “’816 Patent”), as well as Claims 7 and 13 of U.S. Patent No. 8,362,069…, and IV be entered as to U.S. Patent No. 8,815,816, and U.S. Patent No. 8,362,069, as set forth in the…8,362,069 (the “’069 Patent”). Each of the asserted dependent claims in the ’816 Patent depend from independent…; and the asserted dependent claims in the ’069 Patent depend (directly or indirectly) from independent…”); WHEREAS Claims 2 and 11 of the ’816 Patent require, among other things, “a mixture of solvents External link to document
0000-00-00 190 Betensky, Ph.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118; 2) Opening Expert…Gallo M.D., Ph.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118; 3) Expert Report…Todd Plott, M.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118 filed by Teva …2017 29 August 2019 1:17-cv-01783 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 192 Todd Plott, M.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118 3) Rebuttal Expert…Concerning the Non- Infringement of U.S. Patent Nos. 9,089,587, 9,233,117 and 9,233,118 4) Rebuttal Expert…Concerning the Non- Infringement of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118 5) Expert Report…2017 29 August 2019 1:17-cv-01783 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 257 Opinion - Memorandum Opinion related to U.S. Patent Nos. 8,362,069 ("the ' 069 patent"), 8,815,816 ("the ' … the case to three patents-U.S. Patent Nos. 9,089,587 ("the ' 587 patent"), 9,233 ,117 …587 patent, claim 3 of the ' 117 patent, and claim 11 of the ' 118 patent each…117 ("the' 117 patent"), and 9,233 ,118 ("the ' 118 patent") (collectively,…the asserted patents. Galderma asserts infringement of claim 12 of the ' 587 patent, claims 2, 3, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Boehringer Ingelheim
Moodys
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.